UnitedHealth Group Inc (NYSE:UNH) is Handelsbanken Fonder AB’s 5th Largest Position

Share on StockTwits

Handelsbanken Fonder AB grew its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 34.0% in the 2nd quarter, HoldingsChannel reports. The firm owned 823,430 shares of the healthcare conglomerate’s stock after acquiring an additional 209,086 shares during the quarter. UnitedHealth Group accounts for approximately 2.0% of Handelsbanken Fonder AB’s investment portfolio, making the stock its 5th biggest holding. Handelsbanken Fonder AB’s holdings in UnitedHealth Group were worth $242,871,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in UnitedHealth Group by 7.5% in the 2nd quarter. Vanguard Group Inc. now owns 80,727,140 shares of the healthcare conglomerate’s stock worth $23,810,470,000 after acquiring an additional 5,654,194 shares during the last quarter. Fisher Asset Management LLC boosted its stake in UnitedHealth Group by 41,127.3% in the 2nd quarter. Fisher Asset Management LLC now owns 2,347,070 shares of the healthcare conglomerate’s stock worth $692,268,000 after purchasing an additional 2,341,377 shares during the period. APG Asset Management N.V. boosted its stake in UnitedHealth Group by 305.2% in the 1st quarter. APG Asset Management N.V. now owns 2,315,539 shares of the healthcare conglomerate’s stock worth $509,899,000 after purchasing an additional 1,744,138 shares during the period. Nordea Investment Management AB boosted its stake in UnitedHealth Group by 103.1% in the 2nd quarter. Nordea Investment Management AB now owns 2,827,796 shares of the healthcare conglomerate’s stock worth $817,176,000 after purchasing an additional 1,435,755 shares during the period. Finally, Franklin Resources Inc. boosted its stake in UnitedHealth Group by 62.9% in the 1st quarter. Franklin Resources Inc. now owns 2,442,256 shares of the healthcare conglomerate’s stock worth $609,057,000 after purchasing an additional 943,181 shares during the period. 86.39% of the stock is owned by hedge funds and other institutional investors.

UNH has been the subject of several analyst reports. Goldman Sachs Group began coverage on UnitedHealth Group in a research note on Friday, June 5th. They issued a “buy” rating and a $384.00 target price for the company. Jefferies Financial Group lifted their price target on UnitedHealth Group from $283.00 to $295.00 and gave the company a “hold” rating in a research report on Friday, July 10th. Morgan Stanley reiterated a “buy” rating and set a $371.00 price target on shares of UnitedHealth Group in a research report on Thursday, July 16th. Bank of America lifted their price target on UnitedHealth Group from $351.00 to $365.00 and gave the company a “buy” rating in a research report on Friday, August 28th. Finally, Raymond James lifted their price target on UnitedHealth Group from $325.00 to $350.00 and gave the company a “strong-buy” rating in a research report on Thursday, July 16th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, twenty-one have given a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $339.52.

UnitedHealth Group stock traded down $2.19 during trading hours on Tuesday, reaching $306.38. The company had a trading volume of 38,062 shares, compared to its average volume of 4,451,698. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.84 and a quick ratio of 0.84. The company has a 50-day moving average price of $311.63 and a 200 day moving average price of $288.18. The firm has a market cap of $293.25 billion, a price-to-earnings ratio of 17.51, a P/E/G ratio of 1.44 and a beta of 0.68. UnitedHealth Group Inc has a 12-month low of $187.72 and a 12-month high of $324.57.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, July 15th. The healthcare conglomerate reported $7.12 EPS for the quarter, topping the Zacks’ consensus estimate of $5.28 by $1.84. The business had revenue of $62.10 billion for the quarter, compared to analysts’ expectations of $63.54 billion. UnitedHealth Group had a return on equity of 29.28% and a net margin of 6.90%. The business’s quarterly revenue was up 2.5% on a year-over-year basis. During the same period in the previous year, the firm earned $3.60 EPS. As a group, research analysts expect that UnitedHealth Group Inc will post 16.58 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be paid a $1.25 dividend. The ex-dividend date is Friday, September 11th. This represents a $5.00 dividend on an annualized basis and a yield of 1.63%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.09%.

In other news, EVP Marianne D. Short sold 12,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $321.34, for a total transaction of $3,856,080.00. Following the transaction, the executive vice president now directly owns 140,885 shares of the company’s stock, valued at $45,271,985.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Stephen J. Hemsley sold 59,012 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 16th. The shares were sold at an average price of $307.04, for a total value of $18,119,044.48. Following the sale, the director now owns 909,059 shares in the company, valued at $279,117,475.36. The disclosure for this sale can be found here. Insiders sold a total of 128,522 shares of company stock worth $39,886,448 over the last ninety days. Insiders own 0.80% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: What is a balanced fund?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.